Chasing Life
The Big Business Behind Weight Loss Drugs
Feb 6, 2024
The podcast explores the booming business of weight loss drugs, discussing their popularity, profitability, and impact on food and healthcare. It delves into the challenges faced by pharmaceutical companies, the business strategies behind drug pricing, and the potential societal implications. The episode also highlights the potential benefits of more affordable weight loss drugs and the use of these medications by companies like Weight Watchers.
33:54
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Weight loss medications like Ozempic and Wegovy have shown remarkable results, achieving up to 22% weight loss over 72 weeks, surpassing previous medications that only achieved 5-10% weight loss.
- The weight loss medication market is projected to reach $100 billion in annual revenue by 2030, leading to shortages and increased pressure on pharmaceutical companies to meet the skyrocketing demand.
Deep dives
The Rise of Weight Loss Medications
Weight loss medications, such as GLP1 drugs like Ozempic and Wagovi, have become a booming industry, surpassing expectations. These drugs have achieved significant weight loss results, with the latest drugs showing up to 22% weight loss over 72 weeks, far surpassing previous medications that only achieved 5-10% weight loss. The demand for these medications has soared, with more than 9 million prescriptions written in the last three months of 2022 alone. Despite their high cost (over $1,000 per month), demand is expected to increase even further, making weight loss medications a lucrative business.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
